EAS Newsletter December 6, 2023

EAS Society:

Introducing the new membership process. What changes can existing EAS members expect?

Starting in 2024, we will strengthen our community with updated processes for member application and renewal. This will require upload of any two of the following documents in English, preferably in PDF or MS Word format:

  • Short CV
  • A scientific publication where you are listed as an author 
  • A congress abstract that you have presented, or where you are listed as an author 
  • A letter showing your status of employment or study  
  • A letter of recommendation from an existing EAS member 

If you are an existing EAS member, you will receive an email notification when your membership is due for renewal.

Simply saying, there’s nothing to worry about!

Read more about the new membership process

EAS Congress:

Get a special early registration rate until March 14, 2024

Take advantage of a exclusive early registration rate available until March 14, 2024. It’s important to note that in order to qualify for the EAS member registration fee for the EAS 2024 Lyon, you must have settled your EAS individual membership fee for 2023 with the Society. If your EAS membership fee for 2023 remains unpaid by the year’s end, the non-member registration fee will be applicable at the EAS 2024 Lyon.

Act promptly and secure your spot!

To the registration for the EAS Congress 2024

EAS Governance:

The deadline for abstract submission for the EAS Congress 2024 has been extended until December 12

The deadline for abstract submissions for the EAS Congress 2024 has been extended until December 12, 2023!

If you have groundbreaking research in atherosclerosis that you couldn’t submit earlier, seize this opportunity to be part of the EAS 2024 Congress.

Engage with colleagues from around the world, enhance your career, and gain valuable feedback on your work. Now is your chance to shine and contribute to the advancement of this vital field.

We also welcome your contributions to the scientific dialogue at EAS 2024. Submit an abstract in one of our four main topics:

– Pathogenesis of Atherosclerosis
– Lipids and Lipoproteins
– Dyslipidemia and Risk Factors
– Clinical Vascular Disease

Your insights and research will play a pivotal role in furthering our understanding of atherosclerosis. Explore the detailed list of topics and submit your abstract for an oral or poster presentation today by clicking the links below.

Scientific topics

Grants and fellowships related to the EAS Congress

Submit your abstract

EAS Collaborations:

The success of the 20th European Angiology Days, International Vascular Medicine Academic Yearly Conference

We are pleased to share that our involvement in the 20th European Angiology Days has been acknowledged, with organizers receiving numerous congratulatory emails praising the quality of the topics, presentations, and discussions. We look forward to maintaining a strong collaboration with VAS.

The success of the event can be attributed to the exceptional speakers and the competence of the chairpersons. Both EAS and VAS are committed to enhancing quality and knowledge to improve people’s lives, making collaborative efforts seamless and productive.

EAS Collaborations:

Revitalize your understanding of dyslipidemia management and explore the vital role of diet in preventing cardiovascular disease

This online tutorial aims to refresh your knowledge related to the dietary management of dyslipidemias and to highlight how diet and lifestyle interventions can play an important role in the prevention of cardiovascular disease (CVD).

This tutorial was developed for general practitioners (GPs) and healthcare
 professionals (HCPs) in primary care practices to help leverage existing knowledge. The tool can also be a useful resource for medical students.

Discover the latest articles on this topic as well!

To Diet at the Heart

4. How are plant-based diet patterns beneficial in lowering atherogenic blood lipids?

5. Medical nutrition therapy is effective in the management of adult dyslipidaemia – the importance of diet and lifestyle support in the prevention of CVD

6. Consuming a healthy diet is associated with lower cardiovascular disease risk in all regions of the world

EAS Outreach:

Vote Cardiovascular Health 2024!

As a proud partner of the European Alliance for Cardiovascular Health (EACH), we advocate for Cardiovascular Health 2024!

We engage with MEPs, urging for a comprehensive EU policy initiative to enhance the cardiovascular health of European citizens. The exhibition will be hosted by MEP Elżbieta Łukacijewska (PL, EPP) and MEP Radka Maxová (CZ, S&D), both long-time supporters of cardiovascular health in the European Union.

It will take place at the European Parliament in Strasbourg, from December 11th to December 14th.

“Vote Cardiovascular Health 2024” is a unique initiative that zooms in on the critical issue of cardiovascular health, the leading cause of mortality in the EU and worldwide. This event is tailored to inform and engage MEPs and their teams, providing essential insights into the true cost of cardiovascular disease and the significant number of EU citizens affected by it.

To the Vote Cardiovascular Health 2024 website

EAS Outreach:

New media partnership with touchCARDIO

We are pleased to announce our latest media partnership with touchCARDIO. Their expertise in delivering online education has been refined through extensive experience, working alongside numerous distinguished faculty members and several of the world’s foremost medical societies. Now, we are proud to be counted among them.

touchCARDIO takes pride in leading the way in on-demand and virtual formats, consistently pushing the boundaries of online medical education.

To the touchCARDIO website

EAS Outreach:

EAS has endorsed the Global Cholesterol Action Plan!

European Atherosclerosis Society has endorsed the Global Cholesterol Action Plan, bringing the number of signatories to 100!

The GCAP, developed as part of Global Heart Hub’s Invisible Nation project, aims to reduce the impact of atherosclerotic cardiovascular disease (ASCVD), the leading cause of mortality worldwide.

The Action Plan outlines 4 clear goals: build alliances, raise public awareness, activate alliances, and improve high cholesterol detection and management.

Learn more and support the plan